Top Markets
#1 Wrapped STX (Velar) Wrapped STX (Velar) +54.73%
#2 Pons Pons +49.77%
#3 StonkBroker StonkBroker +37.94%
#4 PondCoin PondCoin +37.35%
#5 TENDIES TENDIES +36.53%
#6 Magma Finance Magma Finance +34.48%
#7 Ocean Protocol Ocean Protocol +31.66%
#8 Official Trump Official Trump +27.66%
#9 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +27.14%
#10 Ore Ore +26.90%
Coin of the day
Wrapped STX (Velar) Wrapped STX (Velar)
Configurações
Idioma
PORTUGUêS
Moeda
USD
Tema
Actuate Therapeutics Inc Actuate Therapeutics Inc

Actuate Therapeutics Inc

ACTU
Classificação em ações #28698
Actuate Therapeutics, Inc. is a biopharmaceutical firm operating at the... Actuate Therapeutics, Inc. is a biopharmaceutical firm operating at the clinical stage, dedicated to creating treatments for various cancers. Its primary drug candidate is Elraglusib Injection, an innovative glycogen synthase kinase-3 (GSK-3) inhibitor designed to combat metastatic pancreatic ductal adenocarcinoma. Furthermore, Elraglusib is being developed to address other malignancies, including Ewing sarcoma, metastatic melanoma, and colorectal cancer. Originally named Apotheca Therapeutics, Inc., the organization rebranded as Actuate Therapeutics, Inc. in October 2015. Established in 2015, the company maintains its headquarters in Fort Worth, Texas.
Preço da ação
$1.05
Valor de mercado
$25.12M
Variação (1 dia)
0.00%
Variação (1 ano)
-86.83%
País
US
Negociar Actuate Therapeutics Inc (ACTU)

Categoria

Healthcare
Histórico de preços das ações de Actuate Therapeutics Inc (ACTU)
Preço de fecho mais alto: $1.04 em 2026-08-01

Preço de fecho mais baixo: $8.39 em 2024-08-01
Histórico de preços das ações da Actuate Therapeutics Inc de 2024 a 2026
Desempenho anual do preço das ações
Ano Desempenho
2026 (TTM) -36.39%
2025 -14.02%
2024 0.00%
Preço das ações de empresas similares ou concorrentes
Empresa Preço da ação Variação 1a% País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $552.07 41.28%
US
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $168.77 504.69%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.03K 57.19%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $117.42 -19.34%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $753.28 8.59%
CH